Rhythm Pharmaceuticals, Inc. Common Stock (RYTM) is a publicly traded Healthcare sector company. As of May 21, 2026, RYTM trades at $90.54 with a market cap of $5.95B and a P/E ratio of -28.53. RYTM moved +3.78% today. Year to date, RYTM is -11.02%; over the trailing twelve months it is +41.91%. Its 52-week range spans $45.91 to $122.20. Analyst consensus is strong buy with an average price target of $137.64. Rallies surfaces RYTM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rhythm Pharmaceuticals, Inc. Common Stock (RYTM) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. RYTM moved +3.78% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $90.54 |
| Market Cap | $5.95B |
| P/E Ratio | -28.53 |
| EPS | $-3.13 |
| Dividend Yield | 0.00% |
| 52-Week High | $122.20 |
| 52-Week Low | $45.91 |
| Volume | 390.11K |
| Avg Volume | 0 |
| Revenue (TTM) | $217.16M |
| Net Income | $-202.68M |
| Gross Margin | 89.41% |
14 analysts cover RYTM: 0 strong buy, 14 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $137.64.